Skip to content
About
Clinical Trials
Resources
Contact
Menu
About
Clinical Trials
Resources
Contact
LS-P-COASTAL
LS-P-COASTAL: Phase I study of inhibitor of SIRPa-CD47 axis with trastuzumab and deruxtecan for HER2+ solid tumors and cohort for HER2 low breast cancer
Status:
Open
Trial Type:
Breast Cancer
,
Early Phase Trials for Multiple Cancer Types
Contact:
Dr. Stephanie Graff
sgraff1@lifespan.org
